Artisan Pharma (Biotechnology, Health Care) — Funding, Investors & Signals 2026

Artisan Pharma

Pioneering critical-care therapeutics to enhance patient outcomes globally

Founded 2006

Waltham, United States 6 employees Series C Total: $85.38M Biotechnology, Health Care +1

Artisan Pharma, Inc., is a biopharmaceutical company focused on pioneering critical-care therapeutics to enhance patient outcomes globally. The company's slogan "Pioneering critical-care therapeutics to enhance patient outcomes globally" encapsulates their mission to make a significant impact in the field of healthcare. Founded in 2006 and headquartered in Waltham, Massachusetts, Artisan Pharma specializes in providing critical-care and hospital-based therapeutics to patients, treating physicians, and payors both in the United States and internationally. Artisan Pharma's flagship product is ART-123, a novel recombinant and soluble thrombomodulin designed specifically for treating disseminated intravascular coagulation in sepsis. The company has successfully marketed its products in significant regions including Japan, China, Taiwan, and Korea, demonstrating a global expansion strategy. Moreover, their strategic manufacturing alliance with A-Bio Pharma Pte Ltd enables efficient production and distribution of their groundbreaking therapeutics. In terms of investments, Artisan Pharma secured a notable $3.00M Series C investment on 20 July 2010, attracting major investors such as EDBI, New Leaf Venture Partners, Novaquest Capital Management, and NGN Capital. These investments reflect the attractiveness and potential of the company’s innovative approach to improving critical-care treatment. Overall, Artisan Pharma appears to be in a strong position to continue its impactful work in critical-care therapeutics, while also presenting an intriguing opportunity for potential venture capital partners seeking to invest in the biopharmaceutical industry.

Funding Stage	Amount	Investors	Date
Series C	••••••	4	20 Jul 2010
Series B	••••••	3	01 Mar 2010
Debt Financing	••••••	-	20 Jan 2010
Debt Financing	••••••	-	28 Apr 2009
Series A	••••••	3	06 Sep 2006

Funding Stage

Amount

Investors

Lead Investors

Date

Series C

••••••

20 Jul 2010

Series B

••••••

01 Mar 2010

Debt Financing

••••••

20 Jan 2010

Debt Financing

••••••

28 Apr 2009

Series A

••••••

06 Sep 2006

FAQ About Artisan Pharma

Pioneering critical-care therapeutics to enhance patient outcomes globally

Artisan Pharma was founded in 2006.

Artisan Pharma is headquartered in Waltham, United States.

Artisan Pharma operates in the following industries: Biotechnology, Health Care, Health and Wellness.

Artisan Pharma has approximately 6 employees.

Artisan Pharma has completed 5 funding rounds, raising a total of $85.38M. The latest funding stage is Series C.

Top alternatives and competitors to Artisan Pharma include Resonance Pharma, Inc, Corus Pharma, Aquinox Pharmaceuticals, Nereus Pharmaceuticals, CervoMed. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Artisan Pharma and Resonance Pharma, Inc are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Artisan Pharma

General Information

Track Artisan Pharma

Discover More

About Artisan Pharma

Funding Rounds & Investors (5)

Artisan Pharma Alternatives & Competitors

FAQ About Artisan Pharma

Don't just browse. Track.